James Healy insider trades

Open-market stock purchases and sales by James Healy, Unknown at BioAge Labs, Inc, from SEC Form 4 filings since Jan 26, 2010.

Track record: 50% of 20 scored buys are up 5% or more since purchase, averaging -7%.

Recent trades

DateStockTradeValue
Jun 10, 2026BIOA BioAge Labs, IncBought (not open market)—
Jun 10, 2026RAPP Rapport Therapeutics, IncBought (not open market)—
May 4, 2026SPTX Seaport Therapeutics, IncBought (not open market)—
May 4, 2026SPTX Seaport Therapeutics, IncBought (not open market)—
May 4, 2026SPTX Seaport Therapeutics, IncBought (not open market)—
May 4, 2026SPTX Seaport Therapeutics, IncBought (not open market)—

Companies traded

  • BIOA BioAge Labs, Inc: 5 buys, last Jun 10, 2026
  • RAPP Rapport Therapeutics, Inc: 17 buys, last Jun 10, 2026
  • SPTX Seaport Therapeutics, Inc: other filings, last May 4, 2026
  • YMAB Y-mAbs Therapeutics, Inc: 2 buys, last Sep 16, 2025
  • NTRA Natera, Inc: 3 buys, 2 sales, last Apr 25, 2025
  • BOLT Bolt Biotherapeutics, Inc: 1 buy, last Jun 12, 2024
  • KRTX Karuna Therapeutics, Inc: 16 buys, 1 sale, last Mar 18, 2024
  • AVBP ArriVent Biopharma, Inc: 1 buy, last Jan 30, 2024
  • CINC CinCor Pharma, Inc: 3 buys, 1 sale, last Feb 24, 2023
  • CHRS Coherus BioSciences, Inc: 1 buy, 8 sales, last Jan 7, 2022
  • ITRM Iterum Therapeutics plc: 1 buy, last Jan 21, 2020
  • EDGE Edge Therapeutics, Inc: 2 buys, last Jun 20, 2017

Get free alerts when James Healy files a new trade →